Cancer Immunotherapy

Impacting All Cancers

From the preventive vaccine for cervical cancer to the first therapy ever proven to extend the lives of patients with metastatic melanoma, immunology has already led to major treatment breakthroughs for a number of cancers. Every cancer type is unique, though, and immunology and immunotherapy are impacting each cancer in different ways.

The pages below provide brief statistics on each cancer, information on current unmet needs and treatment challenges, and an overview of the current and potential impact of immunotherapy for that cancer. Each page has been reviewed and verified by a dedicated expert in cancer immunotherapy.

Pages for additional cancer types—including cervical and other HPV-related cancers, leukemia, lymphoma, liver cancer, multiple myeloma, sarcoma, and other cancers—will be added shortly.

Cancer Immunotherapy Clinical Trial Finder

Cancer Immunotherapy Clinical Trial Finder

Are you a patient interested in enrolling in a cancer immunotherapy clinical trial? Visit our Clinical Trial Finder page or call us at 1-855-216-0127, Monday through Friday from 8:30 a.m. to 6:00 p.m. ET, to see what clinical trials you may be eligible for.

Learn More

Stay Informed

Stay up-to-date with the latest cancer immunotherapy news from CRI by signing up for our e-newsletter or alerts.

Subscribe

Former CRI Fellow Now Heading Major Research Clinic

Dirk Jager, M.D.

Dr. Dirk Jager discusses how his discovery of antigens as potential targets for cancer vaccines or other immune-based cancer therapies as a CRI postdoc has since allowed him to carry that knowledge into the clinic for patients.

Learn More